New collaboration to aid the development of drugs to treat cancers
By Marlin Communications | Cancer and Cell Biology, Disease Area, Lab, News & Events, Research, Research Area, Tumours, Vascular Biology and Stromal TargetingCancer immunotherapies, including checkpoint blocking antibodies such as MSD’s Keytruda, have shown remarkable results in a number of different cancer types. However the effectiveness of these treatments may be enhanced…
New drug to supercharge immune cells in the fight against cancer
By Marlin Communications | Cancer and Cell Biology, Disease Area, News & Events, Research, Research Area, TumoursMany tumours can become resistant to the body’s immune system by creating a barrier of tangled blood vessels that feed the tumour while locking out immune cells that would attack…
Ground-breaking new study doubles the estimate of our functional genes
By Marlin Communications | Cancer, Cancer and Cell Biology, Disease Area, Genes, Lab, News & Events, Research, Research Area, Systems Biology and GenomicsThe findings, published in Nature, were the latest work of the FANTOM5 consortium, a group of researchers from Japan and Australia led by Professor Alistair Forrest from the Perkins and The University of…
New method to fight hard to treat breast cancers
By Marlin Communications | Breast Cancer, Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research AreaThe research led by Perkins researcher Dr Anabel Sorolla involves the use of nanoparticles to deliver a series of anti-cancer agents directly to the tumour. The study focused on triple…
Perkins researchers turn on cancer killing genes
By Marlin Communications | Cancer and Cell Biology, Cancer Epigenetics, Disease Area, Lab, News & Events, Research, Research Area, TumoursDr Benjamin Garcia Bloj, along with his labmates from the Perkins Cancer Epigenetics Laboratory headed by Associate Professor Pilar Blancafort, used a gene-editing technology called CRISPR to ‘wake up’ key tumour suppressors to…